再鼎醫藥有限公司-ADR
ZLAB · NASDAQ
更新於 2026-10-13 14:04:20
$23.78-3.29%
- 今日最高
- $24.30
- 今日最低
- $23.69
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $24.88
- 昨天收盤價
- $24.59
- 成交量
- 524.51K
- 市值
- $21.86B
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-0.16
昨天價格區間
$24.51$25.00
52週價格區間
$12.31$26.60
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 生物科技
- 總部
- 中國浦東B樓，201203
- 國家
- 中國
- 上市日期
- 2020-09-28
- 財年截止
- 十二月
- 流通股數
- 1.13B
- CIK
- 0001704292
再鼎醫藥有限公司是一家生物製藥公司，在中國從事發現、授權引進、開發及銷售用於治療癌症、自身免疫性疾病及感染性疾病的療法。該公司總部位於中國上海。
財務指標
營業收入
2026-06-30
$106.31M
2026-03-31
$99.61M
2025-12-31
$127.59M
2025-09-30
$116.09M
營業支出
2026-06-30
$134.63M
2026-03-31
$130.55M
2025-12-31
$134.67M
2025-09-30
$118.03M
淨利潤
2026-06-30
-$50.82M
2026-03-31
-$51.01M
2025-12-31
-$50.4M
2025-09-30
-$35.96M
淨利潤率
2026-06-30
-47.8%
2026-03-31
-51.21%
2025-12-31
-39.5%
2025-09-30
-30.97%
每股收益
2026-06-30
$-0.46
2026-03-31
$-0.46
2025-12-31
$-0.46
2025-09-30
$-0.33
息稅折舊攤銷前利潤
2026-06-30
-$46.08M
2026-03-31
-$43.99M
2025-12-31
-$48.05M
2025-09-30
-$30.66M
有效稅率
2026-06-30
1.97%
2026-03-31
-2.9%
2025-12-31
5.48%
2025-09-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $106.31M | $99.61M | $127.59M | $116.09M |
| 營業支出 | $134.63M | $130.55M | $134.67M | $118.03M |
| 淨利潤 | -$50.82M | -$51.01M | -$50.4M | -$35.96M |
| 淨利潤率 | -47.8% | -51.21% | -39.5% | -30.97% |
| 每股收益 | $-0.46 | $-0.46 | $-0.46 | $-0.33 |
| 息稅折舊攤銷前利潤 | -$46.08M | -$43.99M | -$48.05M | -$30.66M |
| 有效稅率 | 1.97% | -2.9% | 5.48% | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。